6 completed. 2 Phase 1, 1 Not applicable, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Wobenzym: new trials by email Literature Review of Wobenzym trials Research Report on Wobenzym
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Investigate the Mechanism of Action of an Oral Enzyme Treatment With Bromelain, Trypsin and Rutoside Versus Placebo in Subjects With OsTeoarthritis Wobenzym®, Placebo - Osteoarthritis | Not applicable | Completed | Mucos Pharma GmbH & Co. KG | 40 | 2021-04-30 | 2024-11-22 |
| The Effects of Enzymes and Flavonoids on Inflammation and Coagulation After Marathon Wobenzym plus, PL 1 - Inflammation, Death, Sudden, Cardiac | Phase 1 | Completed | Technical University of Munich | 160 | 2013-08-01 | 2015-06-30 |
| Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise Wobenzym® plus, Placebo - Muscle Injury, Muscle Soreness | Phase 4 | Completed | Mucos Pharma GmbH & Co. KG | 69 | 2013-02-01 | 2015-08-28 |
| The Safety and Efficacy of an Enzyme Combination in Managing Knee Osteoarthritis Pain in Adults Diclofenac, Wobenzym, Placebo - Wobenzym, Osteoarthritis | Phase 2 | Completed | Atrium Innovations | 150 | 2000-11-01 | 2014-03-17 |
| Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and Tolerance Phlogenzym, Placebo - Thrombophlebitis Leg | Phase 3 | Completed | Mucos Pharma GmbH & Co. KG | 100 | 1996-09-01 | 2018-03-19 |
| The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients Wobenzym - HIV Infections | Phase 1 | Completed | Mucos Pharma GmbH and Co | 2005-06-24 |
Inflammation (2) · Osteoarthritis (2) · AIDS-Related Complex (1) · Acquired Immunodeficiency Syndrome (1) · Blood Coagulation Disorders (1) · Cardiovascular Diseases (1) · Death (1) · Death, Sudden (1) · Death, Sudden, Cardiac (1) · HIV Infections (1) · Heart Diseases (1) · Motor Activity (1) · Myalgia (1) · Pathologic Processes (1) · Respiratory Tract Infections (1)
Mucos Pharma GmbH & Co. KG (3) · Atrium Innovations (1) · Mucos Pharma GmbH and Co (1) · Technical University of Munich (1)
Germany (3) · Belgium (1) · Italy (1) · United States (1)
Didier Urbin-Choffray (1) · Gerhard Stauder, Dr (1) · Helmut Pabst, Dr. med (1) · Jean-Emile Dubuc (1) · Johannes Scherr, Dr. med. (1) · Karl Brabants (1) · Marcel Baumueller, MD (1) · Siddhartha Lieten (1) · Valerie Badot (1)